Board of Vista Pharmaceuticals approves conversion of warrants

Capital Market Last Updated at January 9, 2018 20:04 IST

At meeting held on 09 January 2018

The Board of Vista Pharmaceuticals has approved the conversion of 5 lakh warrants into 5 lakh equity shares of Rs 2 each on preferential basis at an issue price of Rs 50 per share.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, January 09 2018. 19:52 IST